New diabetes clinical trial: The MVP Trial: A Randomized Controlled Trial of Mechanism Guided vs PPI Strategy for Laryngopharyngeal Reflux
Published on: May 30, 2025 at 11:00PM
Conditions: Laryngopharyngeal Reflux; Cough; Throat Clearing; Dysphonia; Reflux
Interventions: Drug: Omeprazole 40 MG; Behavioral: Laryngeal Recalibration Therapy; Behavioral: GERD Lifestyle Recommendations
Sponsors: University of California, San Diego; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting
https://ift.tt/VIOvRhf
Conditions: Laryngopharyngeal Reflux; Cough; Throat Clearing; Dysphonia; Reflux
Interventions: Drug: Omeprazole 40 MG; Behavioral: Laryngeal Recalibration Therapy; Behavioral: GERD Lifestyle Recommendations
Sponsors: University of California, San Diego; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting
https://ift.tt/VIOvRhf
Comments
Post a Comment